US$ 21.22
bpc 157 dosing human BPC-157 (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Guide | KLK
Description
Reduces inflammation effectively

118 A collection of metallosensors (Section 3) are widely accepted to surveil this pool and are thus tuned to effect a regulatory response, over some 12 orders of magnitude of metal concentration

By blocking NNMT, 5-amino-1MQ stimulates an increase in nicotinamide adenine dinucleotide (NAD+), a cofactor that is central to cellular metabolism, thereby increasing metabolic rate and activating a gene called sirtuin-1 (SIRT1)

When we prescribe peptides, we are targeting specific pathways in your body
